Case Report | Pembrolizumab in the Management of Chemorefractory Gestational Choriocarcinoma: Report of Two Cases.

Immunotherapy is a potent weapon in the treatment of GTD and should be considered earlier option as it has the potential to alter the natural history of refractory choriocarcinoma with possible cure.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-09-01
Primary Topic
Gestational Trophoblastic Disease Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report | Pembrolizumab in the Management of Chemorefractory Gestational Choriocarcinoma: Report of Two Cases.

Ajit Venniyoor, Fatma AlZaabi, Suad AlKharusi
PubMed
Gestational Trophoblastic Disease Studies
article

Case Report | Pembrolizumab in the Management of Chemorefractory Gestational Choriocarcinoma: Report of Two Cases.

Ajit Venniyoor, Fatma AlZaabi, Suad AlKharusi
article en

Abstract

Immunotherapy is a potent weapon in the treatment of GTD and should be considered earlier option as it has the potential to alter the natural history of refractory choriocarcinoma with possible cure.

PubMedVol. 1(46)
Royal Hospital (OM)
Openalex Percentile: Top 59%
Gestational Trophoblastic Disease Studies
OpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Case Report | Pembrolizumab in the Management of Chemorefractory Gestational Choriocarcinoma: Report of Two Cases. — Ajit Venniyoor, Fatma AlZaabi, et al. · PubMed (2024) | TGRS Research Map | TGRS